Cost-Benefit of Minimally Invasive Staging of Non-small Cell Lung Cancer: A Decision Tree Sensitivity Analysis
- 1 October 2010
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 5 (10), 1564-1570
- https://doi.org/10.1097/jto.0b013e3181e8b2e6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Recommendations for optimal use of imaging studies to clinically stage mediastinal lymph nodes in non-small-cell lung cancer patientsLung Cancer, 2008
- Invasive Mediastinal Staging of Lung CancerChest, 2007
- Noninvasive Staging of Non-small Cell Lung CancerChest, 2007
- Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Mediastinoscopy - Its Role and Value Today in the Differential Diagnosis of Mediastinal PathologyActa Oncologica, 2001
- The Utility of Transbronchial Needle Aspiration in the Staging of Bronchogenic CarcinomaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- The current role of mediastinoscopy in the evaluation of thoracic diseaseThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Mediastinoscopy in Patients With Presumptive Stage I SarcoidosisChest, 1998
- Underutilization of Transbronchial Needle AspirationChest, 1997
- Flexible Transbronchial Needle Aspiration for Staging of Bronchogenic CarcinomaChest, 1983